May Health
Paris
About May Health
May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience. May Health aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. May Health's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $47.7M
- Last round: Series Unknown (Mar 2026)
- Website: mayhealth.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/may-health-79181 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.